The latest closing stock price for Adaptimmune Therapeutics as of March 31, 2025 is 0.20.
An investor who bought $1,000 worth of Adaptimmune Therapeutics stock at the IPO in 2015 would have $-988 today, roughly -1 times their original investment - a -35.58% compound annual growth rate over 10 years.
The all-time high Adaptimmune Therapeutics stock closing price was 21.12 on June 16, 2015.
The Adaptimmune Therapeutics 52-week high stock price is 1.48, which is 640% above the current share price.
The Adaptimmune Therapeutics 52-week low stock price is 0.20, which is 0% below the current share price.
The average Adaptimmune Therapeutics stock price for the last 52 weeks is 0.87.
An investor who bought $1,000 worth of Adaptimmune Therapeutics stock at the IPO in 2015 would have $-988 today, roughly -1 times their original investment - a -35.58% compound annual growth rate over 10 years.
The all-time high Adaptimmune Therapeutics stock closing price was 21.12 on June 16, 2015.
The Adaptimmune Therapeutics 52-week high stock price is 1.48, which is 640% above the current share price.
The Adaptimmune Therapeutics 52-week low stock price is 0.20, which is 0% below the current share price.
The average Adaptimmune Therapeutics stock price for the last 52 weeks is 0.87.